Jay Friedman

3.5k total citations
55 papers, 2.6k citations indexed

About

Jay Friedman is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jay Friedman has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 26 papers in Immunology and 18 papers in Molecular Biology. Recurrent topics in Jay Friedman's work include Cancer Immunotherapy and Biomarkers (17 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (9 papers). Jay Friedman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (9 papers). Jay Friedman collaborates with scholars based in United States, Germany and Malaysia. Jay Friedman's co-authors include Carter Van Waes, Clint Allen, Paúl E. Clavijo, Zhong Chen, Ellen Moore, Yvette Robbins, Jeffrey Schlom, Paresh Dandona, Husam Ghanim and Priya Mohanty and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Cancer Cell.

In The Last Decade

Jay Friedman

55 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jay Friedman United States	27	1.2k	1.1k	834	355	342	55	2.6k
Fabrice Journé Belgium	35	1.1k 0.9×	616 0.6×	1.4k 1.7×	392 1.1×	353 1.0×	113	3.3k
Hao‐Wei Wang United States	25	979 0.8×	653 0.6×	703 0.8×	351 1.0×	175 0.5×	87	2.4k
Yanhong Ni China	28	578 0.5×	467 0.4×	1.3k 1.6×	801 2.3×	224 0.7×	97	2.4k
Caio A. Leite Brazil	15	598 0.5×	516 0.5×	772 0.9×	172 0.5×	319 0.9×	23	1.7k
Xing Zhang China	27	917 0.7×	327 0.3×	1.2k 1.5×	652 1.8×	423 1.2×	126	2.4k
Mélanie Bruchard France	22	1.5k 1.3×	2.6k 2.5×	1.1k 1.3×	273 0.8×	237 0.7×	31	3.9k
Hazem Ghebeh Saudi Arabia	24	1.8k 1.4×	954 0.9×	733 0.9×	373 1.1×	295 0.9×	52	2.6k
Fanny Chalmin France	21	1.7k 1.4×	2.3k 2.2×	1.1k 1.4×	269 0.8×	229 0.7×	28	3.7k
Yuzhu Hou China	21	663 0.5×	1.1k 1.0×	689 0.8×	231 0.7×	239 0.7×	42	2.0k
Zheng Zhu China	24	973 0.8×	813 0.8×	809 1.0×	306 0.9×	324 0.9×	78	2.2k

Countries citing papers authored by Jay Friedman

Since Specialization

Citations

This map shows the geographic impact of Jay Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Friedman more than expected).

Fields of papers citing papers by Jay Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Friedman. The network helps show where Jay Friedman may publish in the future.

Co-authorship network of co-authors of Jay Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Friedman. A scholar is included among the top collaborators of Jay Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Friedman. Jay Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robbins, Yvette, Jay Friedman, Jason M. Redman, et al.. (2023). Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancer. Oral Oncology. 138. 106309–106309. 6 indexed citations

Norberg, Scott M., Ke Bai, Cem Sievers, et al.. (2023). The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis. Science Translational Medicine. 15(719). eadj0740–eadj0740. 15 indexed citations

Friedman, Jay, Xinping Yang, Punam Thakkar, et al.. (2023). Neoadjuvant chemotherapy enhances tumor‐specific T cell immunity in patients with HPV‐associated oropharyngeal cancer. Head & Neck. 45(9). 2294–2302. 4 indexed citations

Friedman, Jay, Sreenivasulu Gunti, Maxwell Lee, et al.. (2022). Determining if T cell antigens are naturally processed and presented on HLA class I molecules. BMC Immunology. 23(1). 5–5. 3 indexed citations

Sievers, Cem, Yvette Robbins, Ke Bai, et al.. (2021). Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes. Communications Biology. 4(1). 1416–1416. 17 indexed citations

Robbins, Yvette, Sarah Greene, Jay Friedman, et al.. (2020). Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. eLife. 9. 43 indexed citations

Nagaya, Tadanobu, Jay Friedman, Yasuhiro Maruoka, et al.. (2019). Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors. Cancer Immunology Research. 7(3). 401–413. 123 indexed citations

Greene, Sarah, Yvette Robbins, Wojciech K. Mydlarz, et al.. (2019). Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Clinical Cancer Research. 26(6). 1420–1431. 217 indexed citations

Friedman, Jay, Ellen Moore, Paul Zolkind, et al.. (2019). Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells. Clinical Cancer Research. 26(3). 679–689. 57 indexed citations

10.

Clavijo, Paúl E., Jay Friedman, Yvette Robbins, et al.. (2018). Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function. Cancer Immunology Research. 7(2). 282–291. 40 indexed citations

11.

Friedman, Jay, Megan V. Morisada, Lillian Sun, et al.. (2018). Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies. Journal for ImmunoTherapy of Cancer. 6(1). 59–59. 43 indexed citations

12.

Davis, Ruth J., Ellen Moore, Paúl E. Clavijo, et al.. (2017). Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. Cancer Research. 77(10). 2607–2619. 178 indexed citations

13.

Bian, Yansong, Jiawei Han, Suresh Mohan, et al.. (2015). MEK Inhibitor PD-0325901 Overcomes Resistance to CK2 Inhibitor CX-4945 and Exhibits Anti-Tumor Activity in Head and Neck Cancer. International Journal of Biological Sciences. 11(4). 411–422. 33 indexed citations

14.

Friedman, Jay, Michael Y. Hu, Robert Vander Broek, et al.. (2013). HSP90 Inhibitor SNX5422/ 2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma. Translational Oncology. 6(4). 429–IN5. 21 indexed citations

15.

Yang, Xinping, Hai Lü, Bin Yan, et al.. (2011). ΔNp63 Versatilely Regulates a Broad NF-κB Gene Program and Promotes Squamous Epithelial Proliferation, Migration, and Inflammation. Cancer Research. 71(10). 3688–3700. 101 indexed citations

16.

Ghanim, Husam, Jay Friedman, Sanaa Abuaysheh, et al.. (2010). Differential Effects of Cream, Glucose, and Orange Juice on Inflammation, Endotoxin, and the Expression of Toll-Like Receptor-4 and Suppressor of Cytokine Signaling-3. Diabetes Care. 33(5). 991–997. 202 indexed citations

17.

Pernas, Francisco G., Clint Allen, Mary Winters, et al.. (2009). Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer. Clinical Cancer Research. 15(7). 2361–2372. 46 indexed citations

18.

Friedman, Jay, Liesl Nottingham, Praveen Duggal, et al.. (2007). Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer. Clinical Cancer Research. 13(22). 6568–6578. 47 indexed citations

19.

Lee, TL, Xin Yang, Bin Yan, et al.. (2007). A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status. Clinical Cancer Research. 13(19). 5680–5691. 66 indexed citations

20.

Yan, Bin, Xinping Yang, TL Lee, et al.. (2007). Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma. Genome biology. 8(5). R78–R78. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact